BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15254976)

  • 21. Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.
    Ricevuto E; Ficorella C; Fusco C; Cannita K; Tessitore A; Toniato E; Gabriele A; Frati L; Marchetti P; Gulino A; Martinotti S
    Am J Pathol; 1996 Feb; 148(2):405-13. PubMed ID: 8579104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of p53 predicts shorter survival in diffuse type gastric cancer.
    Lee WJ; Shun CT; Hong RL; Wu MS; Chang KJ; Chen KM
    Br J Surg; 1998 Aug; 85(8):1138-42. PubMed ID: 9718015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.
    Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M
    Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival.
    Falchetti M; Saieva C; Lupi R; Masala G; Rizzolo P; Zanna I; Ceccarelli K; Sera F; Mariani-Costantini R; Nesi G; Palli D; Ottini L
    Hum Pathol; 2008 Jun; 39(6):925-32. PubMed ID: 18440592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laser pressure catapulting (LPC): optimization LPC-system and genotyping of colorectal carcinomas.
    Bazan V; La Rocca G; Corsale S; Agnese V; Macaluso M; Migliavacca M; Gregorio V; Cascio S; Sisto PS; Di Fede G; Buscemi M; Fiorentino E; Passantino R; Morello V; Tomasino RM; Russo A
    J Cell Physiol; 2005 Feb; 202(2):503-9. PubMed ID: 15316933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study.
    Russo A; Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Latteri F; Valerio MR; Pantuso G; Morello V; Dardanoni G; Latteri MA; Colucci G; Tomasino RM; Gebbia N
    Cancer; 2001 Jul; 92(2):294-302. PubMed ID: 11466682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
    Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of p53 protein core domain structural alteration on ovarian cancer survival.
    Rose SL; Robertson AD; Goodheart MJ; Smith BJ; DeYoung BR; Buller RE
    Clin Cancer Res; 2003 Sep; 9(11):4139-44. PubMed ID: 14519637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M; Peraud A; Leroch B; Kreth FW
    Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers.
    Beghelli S; de Manzoni G; Barbi S; Tomezzoli A; Roviello F; Di Gregorio C; Vindigni C; Bortesi L; Parisi A; Saragoni L; Scarpa A; Moore PS
    Surgery; 2006 Mar; 139(3):347-56. PubMed ID: 16546499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival.
    Kozomara R; Jović N; Magić Z; Branković-Magić M; Minić V
    J Craniomaxillofac Surg; 2005 Oct; 33(5):342-8. PubMed ID: 16129609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability.
    Mrózek A; Petrowsky H; Sturm I; Kraus J; Hermann S; Hauptmann S; Lorenz M; Dörken B; Daniel PT
    Cell Death Differ; 2003 Apr; 10(4):461-7. PubMed ID: 12719723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsatellite instability and p53 mutations in hepatocellular carcinoma.
    Karachristos A; Liloglou T; Field JK; Deligiorgi E; Kouskouni E; Spandidos DA
    Mol Cell Biol Res Commun; 1999; 2(3):155-61. PubMed ID: 10662591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.
    Yamazaki Y; Chiba I; Hirai A; Notani K; Kashiwazaki H; Tei K; Totsuka Y; Iizuka T; Kohgo T; Fukuda H
    Am J Clin Oncol; 2003 Oct; 26(5):e124-9. PubMed ID: 14528086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age.
    Carvalho R; Milne AN; van Rees BP; Caspers E; Cirnes L; Figueiredo C; Offerhaus GJ; Weterman MA
    J Pathol; 2004 Sep; 204(1):75-83. PubMed ID: 15307140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 null mutations detected by a p53 yeast functional assay predict a poor outcome in young esophageal carcinoma patients.
    Osugi H; Morimura K; Okuda E; Takemura M; Higashino M; Takada N; Kinoshita H
    Int J Oncol; 2002 Sep; 21(3):637-41. PubMed ID: 12168111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
    Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
    Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian cancer genomic instability correlates with p53 frameshift mutations.
    Sood AK; Skilling JS; Buller RE
    Cancer Res; 1997 Mar; 57(6):1047-9. PubMed ID: 9067268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of combined allelic imbalance and mutations of p53 in tumor progression and survival following surgery for colorectal carcinoma.
    Lagerstedt KK; Kressner U; Lönnroth C; Nordgren S; Lundholm K
    Int J Oncol; 2005 Dec; 27(6):1707-15. PubMed ID: 16273227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach].
    Araya JC; Roa JC; Villaseca MA; Roa I; Guzmán P; Alvarado C; Melo A
    Rev Med Chil; 2003 Apr; 131(4):359-65. PubMed ID: 12870229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.